HIGHLIGHTS OF PRESCRIBING INFORM/dr

HIGHLIGHTS OF PRESCRIBING INFORM/drome and erythema mult-Pe-eNDICATIONS AND USAGE--in their iness, Mon or for signs of abnormal behavior. (5ADVERSE REACTIONSMost common adverse reaction(incidence >2%)is diarrhea(6)Limitations of Useg的nmotos 2. a singe dose within 2 days of onset of infuenza. Pregnancy Use i beneft outweighs risk ( 8.1)Recommended dose is 600 mg, administered by intravenousion should be exercised when administered to ainfusion for a minimum of 15 minutes (2.creatinine clearance 30-49See 17 for PATIENT COUNSELING INFORMATIONis mg(2.2)nts with creatinine clearance 10-29Revised: 122014DOSAGE FORMS AND STRENGTHSInjection: 200 mg in 20 mL (10 mg/mL) in a single-use vial(3)FULL PRESCRIBING INFORMATION: CONTENTS.8 USE IN SPECIFIC POPULATIONS2 DOSAGE AND ADMINISTRATION2. 1 Dosage in Acute Uncomplicated Influenza8.5 Geriatric Use2.28. 6 Patients with Impaired Renal Functio8.7 Patients with Senous Influenza Requiring Hospitalization2.4 Drug Compatibility12 CLINICAL PHARMACOLOGY5 WARNINGS AND PRECAUTIONS6. 1 Serious Skin/Hypersensitivity Reactions1225.3 Risk of Bacteria Infections12 4 Microbiology6 ADVERSE REACTIONS13 NONCLINICAL TOXICOLOGYDRUG INTERACTIONS14 CLINICAL STUDIES17 PATIENT COUN SELING INFORMATIONSections or subsections omitted from the full prescribing informationare not listeReference ID: 3676535